Article Details

Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-β ...

Retrieved on: 2021-08-03 09:56:15

Tags for this article:

Click the tags to see associated articles and topics

Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-β .... View article details on hiswai:

Excerpt

(Tachyon), a research and development focused biotechnology company, and AbCellera (Nasdaq: ABCL), a technology company with a centralized ...

Article found on: www.valdostadailytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up